Published in Journal of Experimental Medicine · View the paper (DOI)
A study suggests that regular use of aspirin or other NSAIDs can improve the survival of patients with head and neck squamous cell carcinoma (HNSCC) who have mutations in the PIK3CA gene. This is due to the reduction of prostaglandin E2, an inflammatory molecule that promotes tumor growth.
Coverage from 2 institutions